Viral Hepatitis, Type B

  • Saul Krugman
  • Wolf Szmuness
Part of the Hepatology book series (H, volume 5)


The disease that is recognized as type B hepatitis today was first described in 1885 by Lürman (1). He observed an outbreak of jaundice among shipyard workers who were inoculated with smallpox vaccine two months previously. Later it became clear that the human lymph component of the vaccine was obtained from a donor who undoubtedly was a hepatitis B carrier. Although type B hepatitis was first recognized during this past century, it is likely that it existed as an unrecognized disease for many hundreds of past generations.


Acute Type HBsAg Carrier Hepatoma Patient Smallpox Vaccine Australia Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    LÜRMANA: Eine icterusepidemie.Berlin Klin WOchschr 22:20–23, 1885Google Scholar
  2. 2.
    BLUMBERGBS,ALTERHJ,VISNICHS: A “new” antigen in leukemia sera.JAMA 191; 541–546, 1965PubMedCrossRefGoogle Scholar
  3. 3.
    PRINCEAM: An antigen detected in the blood during the incubation period of serum hepatitis.Proc Natl Acad Sci USA 60: 814–821, 1968.PubMedCrossRefGoogle Scholar
  4. 4.
    DANEDS,CAMERONCH,BRIGGSM: Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.Lancet 1: 695–698, 1970.PubMedCrossRefGoogle Scholar
  5. 5.
    SHIHJWK,COTEPJ Jr,GERINJL: Production of monoclonal antibodies against hepatitis B surface antigen by somatic cell hybrids.J Virol Methods, in press.Google Scholar
  6. 6.
    SNISKYJJ,SIDDIQUIA,ROBINSONWS: Cloning and endonuclease mapping of the hepatitis B viral genome.Nature 279: 346–348, 1979.CrossRefGoogle Scholar
  7. 7.
    SZMUNESSW,HARLEYEJ,IKRAMH, et al: Sociodemographic aspects of the epidemiology of hepatitis B. InViral Hepatitis. GN Vyas, SN Cohen, R Schmid (eds). The Franklin Institute Press, Philadelphia, pp. 297–320.Google Scholar
  8. 8.
    SZMUNESSW,NEURATHAR,STEVENSCE, et al: Prevalence of hepatitis B “e” antigen and its antibody in various HBsAg carrier populations. To be published.Google Scholar
  9. 9.
    SIMONSMJ,YAPEH,YUM, et al: Australia antigen in Singapore Chinese patients with hepatocellular carcinoma and comparison groups: influence of technique on differential frequencies.Int J Cancer 10: 320–325, 1972PubMedCrossRefGoogle Scholar
  10. 10.
    TONGMJ,SUNSC,SCHAEFFERBT, et al: Hepatitis-associated antigen in hepatocellular carcinoma in Taiwan.Ann Int Med 75: 687–691, 1971.PubMedGoogle Scholar
  11. 11.
    SZMUNESSW,STEVENSCE,IKRAMH, et al: Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese Americans.J Infect Dis 137: 822–829, 1978.PubMedCrossRefGoogle Scholar
  12. 12.
    KRUGMANS,GILESJP,HAMMONDJ: Viral hepatitis, type B (MS-2 strain): Studies on active immunization.JAMA 217: 41–45, 1971.PubMedCrossRefGoogle Scholar
  13. 13.
    HILLEMANMR,BUYNAKEG,ROEHMRR, et al: Purified and inactivated hepatitis B vaccine: A progress report.Am J Med Sci 270: 401–404, 1975.PubMedCrossRefGoogle Scholar
  14. 14.
    PURCELLRH,GERINJL: Hepatitis B subunit vaccine: A preliminary report of safety and efficacy tests in chimpanzees.Am J Med Sci 270: 395–399, 1975.PubMedCrossRefGoogle Scholar
  15. 15.
    SZMUNESSW: Large-scale efficacy trials of hepatitis B vaccines in the USA: Baseline data and protocols.J Med Virol 4: 327–340, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    MAUPASP,GOUDEAUA,COURSAGETP et al: Immunization against hepatitis B in man.Lancet 1: 1367–1370, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Saul Krugman
    • 1
    • 2
  • Wolf Szmuness
    • 1
    • 2
  1. 1.Department of PediatricsNew York University Medical CenterUSA
  2. 2.The Lindsley F. Kimball Research InstituteNew York Blood CenterNew YorkUSA

Personalised recommendations